Using the expertise in foot-and-mouth disease at The Pirbright Institute and facilities for determining protein structures at Diamond Light Source and its predecessor the Synchrotron Radiation Source (SRS), researchers have developed a new vaccine against foot-and-mouth disease (FMD).
The new vaccine is synthetic and is not produced from live infectious viruses, making production much safer and cheaper. It also promises to be more effective than current commercially-available vaccines, because it has been designed to trigger an optimum immune response and engineered to be more stable. The improved stability has the benefit of removing the need for refrigeration of the vaccine, making it easier to transport and store.
Last updated: 24 September 2015